marketcaparena

TECH

BIO-TECHNE Corp

Company overview

Market capitalization
$11.37B
Employees
3,000
Latest publication
2026-09-29
About BIO-TECHNE Corp

develop, manufacture and sell life science reagents, instruments and services

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ4 20262026-06-30 · USDQ3 20262026-03-31 · USDQ2 20262025-12-31 · USDQ1 20262025-09-30 · USDQ3 20252025-03-31 · USDQ2 20252024-12-31 · USDQ1 20252024-09-30 · USDQ4 20242024-06-30 · USD
Total Revenue321,191,000USD311,415,000USD295,877,000USD286,555,000USD316,181,000USD297,031,000USD289,458,000USD306,099,000USD
Cost Of Revenue109,797,000USD103,127,000USD104,600,000USD98,443,000USD101,625,000USD103,145,000USD106,441,000USD102,751,000USD
Research Development23,945,000USD23,455,000USD23,125,000USD24,241,000USD24,579,000USD25,016,000USD23,869,000USD23,989,000USD
Selling General Administrative113,172,000USD109,338,000USD113,691,000USD116,213,000USD151,269,000USD121,451,000USD119,161,000USD63,987,000USD
Total Operating Expenses137,117,000USD132,793,000USD136,816,000USD140,454,000USD175,848,000USD146,467,000USD143,030,000USD157,525,000USD
Operating Income74,277,000USD75,495,000USD54,461,000USD47,658,000USD38,708,000USD47,419,000USD39,987,000USD45,823,000USD
Income Before Tax70,681,000USD71,225,000USD50,784,000USD47,991,000USD38,274,000USD42,876,000USD40,171,000USD41,661,000USD
Net Income54,622,000USD51,057,000USD38,009,000USD38,185,000USD22,588,000USD34,890,000USD33,600,000USD40,588,000USD
Gross Profit—208,288,000USD191,277,000USD188,112,000USD214,556,000USD193,886,000USD183,017,000USD203,348,000USD
Interest Income—981,000USD897,000USD971,000USD1,026,000USD1,348,000USD926,000USD905,000USD
Interest Expense—3,222,000USD2,171,000USD2,934,000USD2,007,000USD2,148,000USD2,176,000USD2,509,000USD
Net Interest Income—-1,421,000USD-1,274,000USD-1,963,000USD-981,000USD-800,000USD-1,250,000USD-1,604,000USD
Income Tax Expense—20,178,000USD12,775,000USD9,806,000USD15,686,000USD7,986,000USD6,571,000USD1,073,000USD
Tax Provision—20,178,000USD12,775,000USD9,806,000USD15,686,000USD7,986,000USD6,571,000USD1,073,000USD
Net Income From Continuing Ops—51,047,000USD38,009,000USD38,185,000USD22,588,000USD34,890,000USD33,600,000USD40,588,000USD
Ebit—74,447,000USD52,955,000USD50,925,000USD40,281,000USD45,024,000USD42,347,000USD44,170,000USD
Ebitda—98,616,000USD77,664,000USD75,265,000USD67,852,000USD72,108,000USD70,484,000USD72,227,000USD
Depreciation And Amortization—24,169,000USD24,709,000USD24,340,000USD27,571,000USD27,084,000USD28,137,000USD28,057,000USD
Reconciled Depreciation—24,169,000USD24,709,000USD24,340,000USD27,571,000USD27,084,000USD28,137,000USD28,057,000USD
Total Other Income Expense Net—-4,270,000USD-3,677,000USD333,000USD-434,000USD-4,543,000USD184,000USD-4,162,000USD
Unclassified Operating Expenses———————69,549,000USD
Minority Interest———————0USD
SourceDisclosurePreliminaryLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20262026-06-30 · USDFY 20252025-06-30 · USDFY 20242024-06-30 · USDFY 20232023-06-30 · USDFY 20212021-06-30 · USDFY 20202020-06-30 · USDFY 20192019-06-30 · USDFY 20182018-06-30 · USD
Total Revenue1,215,039,000USD1,219,635,000USD1,159,060,000USD1,136,702,000USD931,032,000USD738,691,000USD714,006,000USD642,993,000USD
Cost Of Revenue415,968,000USD429,363,000USD389,335,000USD366,887,000USD298,182,000USD255,497,000USD240,515,000USD210,850,000USD
Gross Profit799,071,000USD790,272,000USD769,725,000USD769,815,000USD632,850,000USD483,194,000USD473,491,000USD432,143,000USD
Research Development94,766,000USD99,496,000USD96,664,000USD92,493,000USD70,603,000USD65,192,000USD62,413,000USD55,329,000USD
Selling General Administrative452,415,000USD415,097,000USD393,320,000USD352,438,000USD289,924,000USD240,882,000USD236,867,000USD240,636,000USD
Total Operating Expenses547,181,000USD688,017,000USD563,039,000USD470,871,000USD395,554,000USD325,775,000USD326,772,000USD295,965,000USD
Operating Income251,890,000USD102,255,000USD206,686,000USD298,944,000USD237,296,000USD157,419,000USD125,583,000USD136,178,000USD
Total Other Income Expense Net-11,210,000USD-3,792,000USD-20,997,000USD39,715,000USD-89,121,000USD119,058,000USD-34,704,000USD-10,226,000USD
Interest Expense9,630,000USD8,509,000USD15,736,000USD11,215,000USD13,952,000USD19,197,000USD21,705,000USD10,188,000USD
Income Before Tax240,680,000USD98,463,000USD185,689,000USD338,659,000USD148,175,000USD276,477,000USD112,015,000USD125,952,000USD
Income Tax Expense58,818,000USD25,063,000USD17,584,000USD53,217,000USD8,590,000USD47,181,000USD15,943,000USD602,000USD
Equity Method Income Loss887,000USD———————
Net Income181,862,000USD73,400,000USD168,105,000USD285,263,000USD140,410,000USD229,296,000USD96,072,000USD125,350,000USD
Net Income Applicable To Common Shares181,840,000USD——285,263,000USD140,410,000USD229,072,000USD95,967,000USD126,042,000USD
Unclassified Operating Expenses—173,424,000USD——————
Interest Income—3,886,000USD3,323,000USD3,410,000USD473,000USD605,000USD569,000USD409,000USD
Net Interest Income—-4,623,000USD-12,413,000USD-7,805,000USD-13,479,000USD-18,592,000USD-21,136,000USD-9,779,000USD
Tax Provision—25,063,000USD17,584,000USD53,217,000USD8,590,000USD47,181,000USD15,943,000USD-198,000USD
Net Income From Continuing Ops—73,400,000USD168,105,000USD285,442,000USD139,585,000USD229,296,000USD96,072,000USD126,150,000USD
Ebit—106,972,000USD201,425,000USD349,874,000USD162,127,000USD295,674,000USD133,720,000USD136,178,000USD
Ebitda—216,875,000USD313,136,000USD457,112,000USD249,874,000USD378,411,000USD211,891,000USD200,641,000USD
Depreciation And Amortization—109,903,000USD111,711,000USD107,238,000USD87,747,000USD82,737,000USD78,171,000USD64,463,000USD
Reconciled Depreciation—109,903,000USD111,711,000USD107,238,000USD87,747,000USD82,737,000USD78,171,000USD64,463,000USD
Minority Interest—0USD0USD-179,000USD8,263,000USD8,263,000USD8,263,000USD8,263,000USD
Selling And Marketing Expenses——69,549,000USD25,940,000USD35,027,000USD19,701,000USD27,492,000USD—
Non Operating Income Net Other———50,930,000USD-75,169,000USD138,255,000USD-12,999,000USD-38,000USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ4 20262026-06-30 · USDQ3 20262026-03-31 · USDQ2 20262025-12-31 · USDQ1 20262025-09-30 · USDQ4 20252025-06-30 · USDQ3 20252025-03-31 · USDQ2 20252024-12-31 · USDQ1 20252024-09-30 · USD
Total Assets2,586,726,000USD2,550,601,000USD2,522,699,000USD2,526,148,000USD2,557,868,000USD2,644,259,000USD2,670,424,000USD2,736,017,000USD
Cash And Equivalents264,712,000USD———————
Total Current Assets744,401,000USD688,050,000USD637,432,000USD609,507,000USD608,300,000USD627,240,000USD634,640,000USD648,567,000USD
Other Current Assets67,360,000USD59,140,000USD74,492,000USD77,460,000USD49,792,000USD58,347,000USD50,778,000USD52,298,000USD
Other Non Current Assets264,336,000USD———————
Total Liabilities478,505,000USD———————
Total Current Liabilities163,700,000USD153,278,000USD140,426,000USD144,545,000USD175,849,000USD169,204,000USD161,256,000USD142,128,000USD
Other Current Liabilities4,025,000USD———————
Other Non Current Liabilities21,345,000USD———————
Total Stockholder Equity2,108,221,000USD2,085,304,000USD2,010,989,000USD1,965,814,000USD1,918,808,000USD2,018,025,000USD2,078,492,000USD2,138,650,000USD
Total Equity Including Noncontrolling Interest2,108,221,000USD———————
Long Term Debt200,000,000USD200,000,000USD260,000,000USD300,000,000USD346,000,000USD330,000,000USD300,000,000USD300,000,000USD
Deferred Revenue36,072,000USD———————
Net Receivables216,585,000USD217,916,000USD184,614,000USD183,897,000USD206,876,000USD237,140,000USD217,940,000USD223,688,000USD
Inventory195,744,000USD201,175,000USD205,447,000USD203,188,000USD189,446,000USD191,083,000USD188,373,000USD185,041,000USD
Property Plant Equipment Net299,169,000USD301,306,000USD302,632,000USD311,059,000USD319,118,000USD335,766,000USD335,136,000USD343,160,000USD
Goodwill975,355,000USD———————
Intangible Assets303,465,000USD319,074,000USD334,990,000USD350,107,000USD365,599,000USD443,699,000USD461,051,000USD486,004,000USD
Accounts Payable26,699,000USD23,490,000USD26,269,000USD30,157,000USD25,311,000USD31,644,000USD33,120,000USD31,559,000USD
Short Term Debt14,935,000USD14,181,000USD13,710,000USD13,771,000USD14,098,000USD14,049,000USD13,511,000USD13,485,000USD
Common Stock1,561,000USD1,565,000USD1,559,000USD1,557,000USD1,550,000USD1,568,000USD1,579,000USD1,589,000USD
Retained Earnings1,144,188,000USD1,145,192,000USD1,106,819,000USD1,082,534,000USD1,066,049,000USD1,196,385,000USD1,286,699,000USD1,341,175,000USD
Accumulated Other Comprehensive Income-70,580,000USD-66,855,999USD-62,344,000USD-64,395,000USD-59,880,000USD-82,052,000USD-85,650,000USD-60,087,000USD
Short Long Term Debt200,000,000USD———————
Total Liab—465,297,000USD511,710,000USD560,334,000USD639,060,000USD626,234,000USD591,932,000USD597,367,000USD
Other Current Liab—74,203,000USD66,941,000USD67,324,000USD93,099,000USD87,614,000USD83,769,000USD67,334,000USD
Capital Stock—1,565,000USD1,559,000USD1,557,000USD1,550,000USD1,568,000USD1,579,000USD1,589,000USD
Good Will—977,800,000USD980,561,000USD978,912,000USD980,935,000USD968,612,000USD964,607,000USD982,585,000USD
Cash—209,819,000USD172,879,000USD144,962,000USD162,186,000USD140,670,000USD177,549,000USD187,540,000USD
Cash And Short Term Investments—209,819,000USD172,879,000USD144,962,000USD162,186,000USD140,670,000USD177,549,000USD187,540,000USD
Current Deferred Revenue—38,433,000USD31,030,000USD30,445,000USD32,571,000USD32,269,000USD27,715,000USD26,614,000USD
Net Debt—80,503,000USD178,016,000USD249,511,000USD281,872,000USD282,829,000USD217,578,000USD211,378,000USD
Short Long Term Debt Total—290,322,000USD350,895,000USD394,473,000USD444,058,000USD423,499,000USD395,127,000USD398,918,000USD
Long Term Investments—246,028,000USD250,036,000USD258,607,000USD250,983,000USD254,515,000USD256,354,000USD256,308,000USD
Property Plant Equipment Gross—602,123,000USD595,741,000USD600,040,000USD605,249,000USD614,557,000USD605,449,000USD608,422,000USD
Common Stock Shares Outstanding—156,943,000shares156,999,000shares156,362,000shares155,757,000shares158,944,000shares160,626,000shares161,115,000shares
Non Current Assets Total—1,862,551,000USD1,885,267,000USD1,916,641,000USD1,949,568,000USD2,017,064,000USD2,035,784,000USD2,087,450,000USD
Non Current Liabilities Total—312,019,000USD371,284,000USD415,789,000USD463,211,000USD457,030,000USD430,676,000USD455,239,000USD
Non Current Liabilities Other—21,668,000USD23,078,000USD23,814,000USD27,082,000USD15,656,000USD11,337,000USD19,789,000USD
Non Currrent Assets Other—10,224,000USD17,048,000USD10,212,000USD22,626,000USD14,472,000USD18,636,000USD19,393,000USD
Net Working Capital—534,772,000USD497,006,000USD464,962,000USD432,451,000USD458,036,000USD473,384,000USD506,439,000USD
Unclassified Current Liabilities—2,971,000USD2,476,000USD2,848,000USD10,770,000USD3,628,000USD3,141,000USD3,136,000USD
Unclassified Non Current Liabilities—90,351,000USD88,206,000USD91,975,000USD90,129,000USD111,374,000USD119,339,000USD135,450,000USD
Unclassified Equity—1,003,837,999USD963,396,000USD944,561,000USD909,539,000USD900,556,000USD874,285,000USD854,384,000USD
Short Term Investments————0USD0USD0USD0USD
Other Assets—————-45,000USD——
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20262026-06-30 · USDFY 20252025-06-30 · USDFY 20242024-06-30 · USDFY 20232023-06-30 · USDFY 20222022-06-30 · USDFY 20212021-06-30 · USDFY 20202020-06-30 · USDFY 20192019-06-30 · USD
Long term debt obligations200,000,000USD———————
Trade accounts payable26,699,000USD———————
Deferred income taxes19,308,000USD———————
Contract liabilities36,072,000USD———————
Right of use assets67,333,000USD———————
Intangible assets, net303,465,000USD———————
Total current assets744,401,000USD———————
Other current assets67,360,000USD———————
Inventories195,744,000USD———————
Cash and cash equivalents264,712,000USD———————
Property and equipment, net231,836,000USD———————
Goodwill975,355,000USD———————
Total current liabilities163,700,000USD———————
Operating lease liabilities current14,935,000USD———————
Other current liabilities4,025,000USD———————
Other assets264,336,000USD———————
Accumulated other comprehensive loss-70,580,000USD———————
Total liabilities and shareholders’ equity2,586,726,000USD———————
Common stock, par value $.01 per share; authorized 400,000,000; issued and outstanding 156,095,113 and 154,972,196 respectively1,561USD/share———————
Income taxes payable3,593,000USD———————
Operating lease liabilities74,152,000USD———————
Additional paid in capital1,033,052,000USD———————
Accrued expenses20,458,000USD———————
Total shareholders’ equity2,108,221,000USD———————
Retained earnings1,144,188,000USD———————
Salaries, wages and related accruals57,918,000USD———————
Other long term liabilities21,345,000USD———————
Accounts receivable, less allowances of $4,644 and $4,215, respectively216,585,000USD———————
Total assets2,586,726,000USD———————
Total Assets—2,557,868,000USD2,703,867,000USD2,638,692,000USD2,294,805,000USD2,262,957,000USD2,027,589,000USD1,884,410,000USD
Intangible Assets—365,599,000USD507,081,000USD534,645,000USD531,522,000USD615,968,000USD516,545,000USD579,429,000USD
Other Current Assets—49,792,000USD43,431,000USD27,066,000USD22,856,000USD16,919,000USD24,341,000USD18,058,000USD
Total Liab—639,060,000USD635,017,000USD672,176,000USD593,794,000USD691,723,000USD646,397,000USD718,821,000USD
Total Stockholder Equity—1,918,808,000USD2,068,850,000USD1,966,516,000USD1,701,770,000USD1,562,971,000USD1,381,192,000USD1,165,589,000USD
Other Current Liab—93,099,000USD76,855,000USD56,540,000USD81,082,000USD74,467,000USD46,118,000USD58,427,000USD
Common Stock—1,550,000USD1,582,000USD1,576,000USD1,566,000USD390,000USD385,000USD379,000USD
Capital Stock—1,550,000USD1,582,000USD1,576,000USD392,000USD390,000USD385,000USD379,000USD
Retained Earnings—1,066,049,000USD1,325,247,000USD1,309,461,000USD1,122,937,000USD1,085,461,000USD1,057,470,000USD931,934,000USD
Good Will—980,935,000USD972,663,000USD872,737,000USD822,101,000USD843,067,000USD728,308,000USD732,667,000USD
Cash—162,186,000USD151,791,000USD180,571,000USD172,567,000USD199,091,000USD146,625,000USD100,886,000USD
Cash And Short Term Investments—162,186,000USD152,863,000USD204,310,000USD247,029,000USD231,554,000USD270,893,000USD166,033,000USD
Total Current Assets—608,300,000USD617,419,000USD621,482,000USD605,556,000USD510,606,000USD520,920,000USD412,607,000USD
Total Current Liabilities—175,849,000USD159,379,000USD128,509,000USD176,018,000USD152,284,000USD106,668,000USD101,985,000USD
Current Deferred Revenue—32,571,000USD27,930,000USD23,069,000USD23,406,000USD18,995,000USD13,049,000USD9,084,000USD
Net Debt—281,872,000USD267,747,000USD274,394,000USD153,404,000USD221,463,000USD286,901,000USD404,274,000USD
Short Term Debt—14,098,000USD12,920,000USD11,199,000USD24,428,000USD24,102,000USD22,035,000USD12,500,000USD
Short Long Term Debt Total—444,058,000USD419,538,000USD454,965,000USD325,971,000USD420,554,000USD433,526,000USD505,160,000USD
Long Term Debt—346,000,000USD319,000,000USD350,000,000USD243,410,000USD328,827,000USD344,243,000USD492,660,000USD
Long Term Investments—250,983,000USD242,337,000USD255,857,000USD25,000,000USD———
Short Term Investments—0USD1,072,000USD23,739,000USD74,462,000USD32,463,000USD124,268,000USD65,147,000USD
Net Receivables—206,876,000USD241,394,000USD218,468,000USD194,548,000USD145,385,000USD122,534,000USD137,466,000USD
Inventory—189,446,000USD179,731,000USD171,638,000USD141,123,000USD116,748,000USD103,152,000USD91,050,000USD
Accounts Payable—25,311,000USD37,968,000USD25,679,000USD33,865,000USD29,384,000USD23,090,000USD16,210,000USD
Property Plant Equipment Net—319,118,000USD342,439,000USD324,526,000USD288,798,000USD281,741,000USD248,294,000USD154,039,000USD
Property Plant Equipment Gross—605,249,000USD598,995,000USD324,526,000USD288,798,000USD281,741,000USD248,294,000USD154,039,000USD
Accumulated Other Comprehensive Income—-59,880,000USD-78,316,000USD-66,064,000USD-75,200,000USD-57,291,000USD-97,199,000USD-83,521,000USD
Common Stock Shares Outstanding—159,717,000shares160,774,000shares161,855,000shares164,116,000shares161,932,000shares157,604,000shares155,568,000shares
Non Current Assets Total—1,949,568,000USD2,086,448,000USD2,017,210,000USD1,689,249,000USD1,752,351,000USD1,506,669,000USD1,471,803,000USD
Non Current Liabilities Total—463,211,000USD475,638,000USD543,667,000USD417,776,000USD539,439,000USD539,729,000USD616,836,000USD
Non Current Liabilities Other—27,082,000USD13,157,000USD10,919,000USD12,239,000USD24,462,000USD26,949,000USD25,222,000USD
Non Currrent Assets Other—22,626,000USD21,928,000USD29,445,000USD46,828,000USD11,300,000USD13,522,000USD5,668,000USD
Net Working Capital—432,451,000USD458,040,000USD492,973,000USD429,538,000USD358,322,000USD414,252,000USD310,622,000USD
Unclassified Current Liabilities—10,770,000USD3,706,000USD12,022,000USD—-7,164,000USD-10,124,000USD-6,736,000USD
Unclassified Non Current Liabilities—90,129,000USD143,481,000USD-6,135,000USD-53,100,000USD-49,962,000USD-43,460,000USD-102,518,000USD
Unclassified Equity—909,539,000USD818,755,000USD719,967,000USD652,075,000USD534,021,000USD420,151,000USD316,418,000USD
Deferred Long Term Liab———88,982,000USD98,994,000USD93,125,000USD101,090,000USD89,754,000USD
Other Liab———99,901,000USD116,233,000USD142,987,000USD110,907,000USD111,718,000USD
Other Assets———12,588,000USD46,828,000USD11,575,000USD13,522,000USD5,668,000USD
Net Tangible Assets———652,900,000USD347,388,000USD112,199,000USD136,339,000USD-146,507,000USD
Short Long Term Debt————12,500,000USD12,500,000USD12,500,000USD12,500,000USD
Unclassified Non Current Assets————-71,828,000USD———
SourceDisclosureVerifiedLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20262026-06-30 · USDFY 20252025-06-30 · USDFY 20242024-06-30 · USDFY 20232023-06-30 · USDFY 20222022-06-30 · USDFY 20212021-06-30 · USDFY 20202020-06-30 · USDFY 20192019-06-30 · USD
Proceeds from sale of assets held for sale4,617,000USD———————
Loss on investments-5,862,000USD———————
Trade accounts and other receivables, net-10,793,000USD———————
Prepaid expenses-5,264,000USD———————
Net cash used in financing activities-169,114,000USD———————
Leases, net-2,983,000USD———————
Depreciation and amortization97,359,000USD———————
Stock based compensation expense41,365,000USD———————
Repayments of long term debt-146,000,000USD———————
Repurchases of common stock-41,675,000USD———————
Cash and cash equivalents at end of period264,712,000USD———————
Net cash provided by operating activities292,073,000USD———————
Cash dividends-49,916,000USD———————
Trade accounts payable, accrued expenses, contract liabilities, and other3,180,000USD———————
Effect of exchange rate changes on cash and cash equivalents-2,243,000USD———————
Inventories-8,232,000USD———————
Asset impairment restructuring3,914,000USD———————
Taxes paid on RSUs and net share settlements-12,141,000USD———————
Proceeds from stock option exercises80,618,000USD———————
Deferred income taxes13,196,000USD———————
Other operating activity477,000USD———————
Net earnings181,862,000USD———————
Income taxes payable-23,051,000USD———————
Net cash used in investing activities-18,190,000USD———————
(Recovery) Impairment of assets held for sale-6,789,000USD———————
Additions to property and equipment-28,850,000USD———————
Net change in cash and cash equivalents102,526,000USD———————
Distributions from Wilson Wolf6,043,000USD———————
(Gain) Loss on equity method investment-887,000USD———————
Salaries, wages and related accruals-7,671,000USD———————
Net Income—73,400,000USD168,072,000USD285,442,000USD263,099,000USD139,585,000USD229,296,000USD96,072,000USD
Depreciation—109,903,000USD111,711,000USD107,238,000USD101,069,000USD87,747,000USD82,737,000USD78,171,000USD
Stock Based Compensation—40,833,000USD38,042,000USD39,230,000USD42,183,000USD48,982,000USD32,367,000USD32,280,000USD
Other Non Cash Items—102,988,000USD30,709,000USD-99,763,000USD-18,378,000USD74,018,000USD-147,067,000USD16,429,000USD
Change To Account Receivables—42,601,000USD-31,132,000USD-20,867,000USD-57,596,000USD-15,549,000USD6,556,000USD-2,700,000USD
Change To Inventory—-18,144,000USD-14,215,000USD400,000USD-32,007,000USD-7,140,000USD-14,861,000USD-13,647,000USD
Change In Working Capital—11,539,000USD-10,106,000USD-48,187,000USD-69,517,000USD29,263,000USD-5,246,000USD-27,751,000USD
Total Cash From Operating Activities—287,556,000USD298,981,000USD254,393,000USD325,272,000USD352,164,000USD205,217,000USD181,619,000USD
Capital Expenditures—-31,006,000USD-62,877,000USD-38,244,000USD-44,908,000USD-44,301,000USD-51,744,000USD-25,411,000USD
Free Cash Flow—256,550,000USD236,104,000USD216,149,000USD280,364,000USD307,863,000USD153,473,000USD156,208,000USD
Investments—-35,183,000USD-203,030,000USD-265,649,000USD-96,851,000USD-243,516,000USD76,933,000USD-21,896,000USD
Total Cashflows From Investing Activities—-35,183,000USD-203,030,000USD-265,649,000USD-96,851,000USD-243,516,000USD27,095,000USD-336,799,000USD
Net Borrowings—27,000,000USD-31,000,000USD94,000,000USD-85,500,000USD-15,500,000USD-148,500,000USD166,500,000USD
Total Cash From Financing Activities—-253,905,000USD-122,398,000USD22,616,000USD-242,853,000USD-62,551,000USD-183,802,000USD134,384,000USD
Dividends Paid—-50,391,000USD-50,419,000USD-50,285,000USD-50,185,000USD-49,622,000USD-48,902,000USD-48,364,000USD
Sale Purchase Of Stock—-275,731,000USD-80,042,000USD-19,562,000USD-160,950,000USD-43,178,000USD-50,112,000USD-15,405,000USD
Change In Cash—10,395,000USD-28,780,000USD8,004,000USD-26,524,000USD52,466,000USD45,739,000USD-21,104,000USD
Begin Period Cash Flow—151,791,000USD180,571,000USD172,567,000USD199,091,000USD146,625,000USD100,886,000USD121,990,000USD
End Period Cash Flow—162,186,000USD151,791,000USD180,571,000USD172,567,000USD199,091,000USD146,625,000USD100,886,000USD
Other Cashflows From Investing Activities—15,264,000USD6,997,000USD-27,965,000USD-51,943,000USD-225,908,000USD1,906,000USD-21,896,000USD
Other Cashflows From Financing Activities—45,217,000USD39,063,000USD92,463,000USD143,782,000USD-19,343,000USD-7,271,000USD31,653,000USD
Unclassified Operating Cash Flow—-51,107,000USD-39,447,000USD-29,567,000USD6,816,000USD-27,431,000USD13,130,000USD-13,582,000USD
Unclassified Investing Cash Flow—15,742,000USD55,880,000USD66,209,000USD96,851,000USD270,209,000USD—-267,596,000USD
Change To Liabilities———-34,958,000USD12,741,000USD19,091,000USD5,664,000USD1,594,000USD
Cash And Cash Equivalents Changes———11,360,000USD-14,432,000USD46,097,000USD48,510,000USD-21,104,000USD
Unclassified Financing Cash Flow———-94,000,000USD-90,000,000USD65,092,000USD70,983,000USD—
Exchange Rate Changes———————-308,000USD
SourceDisclosureVerifiedLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ3 20262026-03-31 · USDQ2 20262025-12-31 · USDQ1 20262025-09-30 · USDQ4 20252025-06-30 · USDQ3 20252025-03-31 · USDQ2 20252024-12-31 · USDQ1 20252024-09-30 · USDQ4 20242024-06-30 · USD
Net Income51,047,000USD38,009,000USD38,185,000USD-17,678,000USD22,588,000USD34,887,000USD33,600,000USD40,578,000USD
Depreciation24,169,000USD24,709,000USD24,340,000USD27,111,000USD27,571,000USD27,084,000USD28,137,000USD28,057,000USD
Stock Based Compensation10,495,000USD13,958,000USD11,682,000USD4,550,000USD11,391,000USD14,708,000USD10,184,000USD7,063,000USD
Other Non Cash Items2,229,000USD-37,042,000USD-9,048,000USD94,930,000USD-2,533,000USD18,257,000USD7,045,000USD19,585,000USD
Change To Account Receivables-31,256,000USD-22,392,000USD22,392,000USD45,242,000USD-15,669,000USD-623,000USD21,563,000USD-17,922,000USD
Change To Inventory3,431,000USD14,002,000USD-14,002,000USD-6,604,000USD173,000USD-8,908,000USD188,000USD-4,616,000USD
Change In Working Capital-4,121,000USD42,849,000USD-42,849,000USD21,570,000USD-12,489,000USD12,195,000USD-9,737,000USD-10,236,000USD
Total Cash From Operating Activities86,661,000USD82,411,000USD27,585,000USD98,201,000USD41,120,000USD84,346,000USD63,889,000USD75,496,000USD
Capital Expenditures-9,086,000USD-5,921,000USD-5,363,000USD-4,890,000USD-10,123,000USD-6,821,000USD-9,172,000USD-17,980,000USD
Free Cash Flow77,575,000USD76,490,000USD22,222,000USD93,311,000USD30,997,000USD77,525,000USD54,717,000USD57,516,000USD
Investments0USD0USD605,000USD406,000USD-8,873,000USD-5,032,000USD-21,684,000USD-8,808,000USD
Total Cashflows From Investing Activities-5,817,000USD-5,921,000USD605,000USD406,000USD-8,873,000USD-5,032,000USD-21,684,000USD-8,808,000USD
Net Borrowings-60,000,000USD-40,000,000USD-46,000,000USD16,000,000USD30,000,000USD0USD-19,000,000USD—
Total Cash From Financing Activities-42,716,000USD-48,986,000USD-44,204,000USD-90,452,000USD-68,045,000USD-83,837,000USD-11,571,000USD-60,095,000USD
Dividends Paid-12,518,000USD-12,470,000USD-12,444,000USD-12,387,000USD-12,580,000USD-12,736,000USD-12,688,000USD-12,627,000USD
Sale Purchase Of Stock24,000USD-24,000USD-24,000USD-100,057,000USD-100,046,000USD-75,628,000USD—-402,000USD
Change In Cash36,940,000USD27,917,000USD-17,224,000USD21,516,000USD-36,879,000USD-9,991,000USD35,749,000USD11,876,000USD
Begin Period Cash Flow172,879,000USD144,962,000USD162,186,000USD140,670,000USD177,549,000USD187,540,000USD151,791,000USD139,915,000USD
End Period Cash Flow209,819,000USD172,879,000USD144,962,000USD162,186,000USD140,670,000USD177,549,000USD187,540,000USD151,791,000USD
Other Cashflows From Investing Activities9,237,000USD—5,968,000USD5,296,000USD1,250,000USD1,789,000USD1,403,000USD-175,516,000USD
Other Cashflows From Financing Activities-157,000USD-1,255,000USD14,264,000USD5,992,000USD14,872,000USD-1,013,000USD-4,984,000USD22,934,000USD
Unclassified Operating Cash Flow2,842,000USD—5,275,000USD-32,282,000USD-5,408,000USD-22,785,000USD-5,340,000USD-9,551,000USD
Unclassified Investing Cash Flow-5,968,000USD———8,873,000USD5,032,000USD7,769,000USD193,496,000USD
Unclassified Financing Cash Flow29,935,000USD4,763,000USD———5,540,000USD25,101,000USD-70,000,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
Q3 2026Quarterly · 2026-03-31GeographyAPACExcluding Greater China21,820,000USD0001104659-26-056302
Q3 2026Quarterly · 2026-03-31GeographyChina26,012,000USD0001104659-26-056302
Q3 2026Quarterly · 2026-03-31GeographyEMEAExcluding UK73,446,000USD0001104659-26-056302
Q3 2026Quarterly · 2026-03-31GeographyRest of World7,767,000USD0001104659-26-056302
Q3 2026Quarterly · 2026-03-31GeographyUnited Kingdom14,891,000USD0001104659-26-056302
Q3 2026Quarterly · 2026-03-31GeographyUnited States167,479,000USD0001104659-26-056302
Q3 2026Quarterly · 2026-03-31ProductOther325,000USD0001104659-26-056302
Q3 2026Quarterly · 2026-03-31ProductProduct And Services — Consumables257,338,000USD0001104659-26-056302
Q3 2026Quarterly · 2026-03-31ProductProduct And Services — Instruments27,664,000USD0001104659-26-056302
Q3 2026Quarterly · 2026-03-31ProductRoyalty4,967,000USD0001104659-26-056302
Q3 2026Quarterly · 2026-03-31ProductServices21,446,000USD0001104659-26-056302
Q3 2026Quarterly · 2026-03-31SegmentDiagnostics And Spatial Biology85,586,000USD0001104659-26-056302
Q3 2026Quarterly · 2026-03-31SegmentProtein Sciences226,154,000USD0001104659-26-056302
Q2 2026Quarterly · 2025-12-31GeographyAPACExcluding Greater China22,742,000USD0001104659-26-010335
Q2 2026Quarterly · 2025-12-31GeographyChina26,351,000USD0001104659-26-010335
Q2 2026Quarterly · 2025-12-31GeographyEMEAExcluding UK75,354,000USD0001104659-26-010335
Q2 2026Quarterly · 2025-12-31GeographyRest of World11,145,000USD0001104659-26-010335
Q2 2026Quarterly · 2025-12-31GeographyUnited Kingdom13,728,000USD0001104659-26-010335
Q2 2026Quarterly · 2025-12-31GeographyUnited States146,557,000USD0001104659-26-010335
Q2 2026Quarterly · 2025-12-31ProductOther387,000USD0001104659-26-010335
Q2 2026Quarterly · 2025-12-31ProductProduct And Services — Consumables235,443,000USD0001104659-26-010335
Q2 2026Quarterly · 2025-12-31ProductProduct And Services — Instruments29,605,000USD0001104659-26-010335
Q2 2026Quarterly · 2025-12-31ProductRoyalty8,513,000USD0001104659-26-010335
Q2 2026Quarterly · 2025-12-31ProductServices22,316,000USD0001104659-26-010335
Q2 2026Quarterly · 2025-12-31SegmentDiagnostics And Spatial Biology81,180,000USD0001104659-26-010335
Q2 2026Quarterly · 2025-12-31SegmentProtein Sciences215,084,000USD0001104659-26-010335
Q1 2026Quarterly · 2025-09-30GeographyAPACExcluding Greater China19,147,000USD0001104659-25-107053
Q1 2026Quarterly · 2025-09-30GeographyChina24,786,000USD0001104659-25-107053
Q1 2026Quarterly · 2025-09-30GeographyEMEAExcluding UK65,128,000USD0001104659-25-107053
Q1 2026Quarterly · 2025-09-30GeographyRest of World9,049,000USD0001104659-25-107053
Q1 2026Quarterly · 2025-09-30GeographyUnited Kingdom13,205,000USD0001104659-25-107053
Q1 2026Quarterly · 2025-09-30GeographyUnited States155,240,000USD0001104659-25-107053
Q1 2026Quarterly · 2025-09-30ProductProduct And Services — Consumables231,601,000USD0001104659-25-107053
Q1 2026Quarterly · 2025-09-30ProductProduct And Services — Instruments21,826,000USD0001104659-25-107053
Q1 2026Quarterly · 2025-09-30ProductRoyalty5,646,000USD0001104659-25-107053
Q1 2026Quarterly · 2025-09-30ProductServices27,482,000USD0001104659-25-107053
Q1 2026Quarterly · 2025-09-30SegmentDiagnostics And Spatial Biology79,458,000USD0001104659-25-107053
Q1 2026Quarterly · 2025-09-30SegmentProtein Sciences202,188,000USD0001104659-25-107053
Q4 2025Quarterly · 2025-06-30GeographyAPACExcluding Greater China18,886,000USDLegacy provider
Q4 2025Quarterly · 2025-06-30GeographyChina26,905,000USDLegacy provider
Q4 2025Quarterly · 2025-06-30GeographyEMEAExcluding UK70,349,000USDLegacy provider
Q4 2025Quarterly · 2025-06-30GeographyRest of World9,649,000USDLegacy provider
Q4 2025Quarterly · 2025-06-30GeographyUnited Kingdom14,788,000USDLegacy provider
Q4 2025Quarterly · 2025-06-30GeographyUnited States176,388,000USDLegacy provider
Q4 2025Quarterly · 2025-06-30ProductProduct And Services — Consumables252,941,000USDLegacy provider
Q4 2025Quarterly · 2025-06-30ProductProduct And Services — Instruments28,901,000USDLegacy provider
Q4 2025Quarterly · 2025-06-30ProductRoyalty5,506,000USDLegacy provider
Q4 2025Quarterly · 2025-06-30ProductServices29,617,000USDLegacy provider
Q4 2025Quarterly · 2025-06-30SegmentDiagnostics And Spatial Biology89,705,000USDLegacy provider
Q4 2025Quarterly · 2025-06-30SegmentProtein Sciences226,472,000USDLegacy provider
FY 2025Yearly · 2025-06-30GeographyAPACExcluding Greater China77,263,000USD0001558370-25-011716
FY 2025Yearly · 2025-06-30GeographyChina100,463,000USD0001558370-25-011716
FY 2025Yearly · 2025-06-30GeographyEMEAExcluding UK266,305,000USD0001558370-25-011716
FY 2025Yearly · 2025-06-30GeographyRest of World37,547,000USD0001558370-25-011716
FY 2025Yearly · 2025-06-30GeographyUnited Kingdom54,827,000USD0001558370-25-011716
FY 2025Yearly · 2025-06-30GeographyUnited States683,230,000USD0001558370-25-011716
FY 2025Yearly · 2025-06-30ProductProduct And Services — Consumables972,286,000USD0001558370-25-011716
FY 2025Yearly · 2025-06-30ProductProduct And Services — Instruments112,086,000USD0001558370-25-011716
FY 2025Yearly · 2025-06-30ProductRoyalty23,693,000USD0001558370-25-011716
FY 2025Yearly · 2025-06-30ProductServices111,570,000USD0001558370-25-011716
FY 2025Yearly · 2025-06-30SegmentDiagnostics And Spatial Biology346,263,000USD0001558370-25-011716
FY 2025Yearly · 2025-06-30SegmentProtein Sciences870,245,000USD0001558370-25-011716
Q3 2025Quarterly · 2025-03-31GeographyAPACExcluding Greater China21,245,000USD0001104659-26-056302
Q3 2025Quarterly · 2025-03-31GeographyChina24,483,000USD0001104659-26-056302
Q3 2025Quarterly · 2025-03-31GeographyEMEAExcluding UK66,501,000USD0001104659-26-056302
Q3 2025Quarterly · 2025-03-31GeographyRest of World9,179,000USD0001104659-26-056302
Q3 2025Quarterly · 2025-03-31GeographyUnited Kingdom12,852,000USD0001104659-26-056302
Q3 2025Quarterly · 2025-03-31GeographyUnited States181,921,000USD0001104659-26-056302
Q3 2025Quarterly · 2025-03-31ProductOther737,000USD0001104659-26-056302
Q3 2025Quarterly · 2025-03-31ProductProduct And Services — Consumables257,785,000USD0001104659-26-056302
Q3 2025Quarterly · 2025-03-31ProductProduct And Services — Instruments26,111,000USD0001104659-26-056302
Q3 2025Quarterly · 2025-03-31ProductRoyalty5,039,000USD0001104659-26-056302
Q3 2025Quarterly · 2025-03-31ProductServices27,246,000USD0001104659-26-056302
Q3 2025Quarterly · 2025-03-31SegmentDiagnostics And Spatial Biology89,231,000USD0001104659-26-056302
Q3 2025Quarterly · 2025-03-31SegmentProtein Sciences227,687,000USD0001104659-26-056302
Q2 2025Quarterly · 2024-12-31GeographyAPACExcluding Greater China19,010,000USD0001104659-26-010335
Q2 2025Quarterly · 2024-12-31GeographyChina24,754,000USD0001104659-26-010335
Q2 2025Quarterly · 2024-12-31GeographyEMEAExcluding UK70,392,000USD0001104659-26-010335
Q2 2025Quarterly · 2024-12-31GeographyRest of World9,726,000USD0001104659-26-010335
Q2 2025Quarterly · 2024-12-31GeographyUnited Kingdom13,243,000USD0001104659-26-010335
Q2 2025Quarterly · 2024-12-31GeographyUnited States159,906,000USD0001104659-26-010335
Q2 2025Quarterly · 2024-12-31ProductProduct And Services — Consumables230,715,000USD0001104659-26-010335
Q2 2025Quarterly · 2024-12-31ProductProduct And Services — Instruments30,868,000USD0001104659-26-010335
Q2 2025Quarterly · 2024-12-31ProductRoyalty8,098,000USD0001104659-26-010335
Q2 2025Quarterly · 2024-12-31ProductServices27,350,000USD0001104659-26-010335
Q2 2025Quarterly · 2024-12-31SegmentDiagnostics And Spatial Biology84,135,000USD0001558370-25-000689
Q2 2025Quarterly · 2024-12-31SegmentOther Revenues From Business Held For Sale1,849,000USD0001558370-25-000689
Q2 2025Quarterly · 2024-12-31SegmentProtein Sciences211,551,000USD0001558370-25-000689
Q1 2025Quarterly · 2024-09-30GeographyAPACExcluding Greater China18,122,000USD0001104659-25-107053
Q1 2025Quarterly · 2024-09-30GeographyChina24,321,000USD0001104659-25-107053
Q1 2025Quarterly · 2024-09-30GeographyEMEAExcluding UK59,063,000USD0001104659-25-107053
Q1 2025Quarterly · 2024-09-30GeographyRest of World8,993,000USD0001104659-25-107053
Q1 2025Quarterly · 2024-09-30GeographyUnited Kingdom13,944,000USD0001104659-25-107053
Q1 2025Quarterly · 2024-09-30GeographyUnited States165,015,000USD0001104659-25-107053
Q1 2025Quarterly · 2024-09-30ProductProduct And Services — Consumables230,845,000USD0001104659-25-107053
Q1 2025Quarterly · 2024-09-30ProductProduct And Services — Instruments26,206,000USD0001104659-25-107053
Q1 2025Quarterly · 2024-09-30ProductRoyalty5,050,000USD0001104659-25-107053
Q1 2025Quarterly · 2024-09-30ProductServices27,357,000USD0001104659-25-107053
Q1 2025Quarterly · 2024-09-30SegmentDiagnostics And Spatial Biology83,192,000USD0001558370-24-014439
Q1 2025Quarterly · 2024-09-30SegmentOther Revenues From Business Held For Sale2,303,000USD0001558370-24-014439

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.